Factors associated with chronic calcineurin inhibitor nephrotoxicity in children with minimal-change disease.
與最小變病兒童慢性鈣調素抑制劑腎毒性相關的因素。
Ren Fail 2025-03-17
A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.
腎小球基因變異次級蛋白尿症中鈣調神經酶抑制劑的多中心回顧性研究。
Kidney Int 2024-01-05
Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis.
他克莫司透過 TGF-β 依賴機制誘導纖維母細胞向肌纖維母細胞轉化,促進腎纖維化。
Am J Physiol Renal Physiol 2024-03-26
Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting.
資源有限環境中對於鈣調素抑制劑抗藥性、類固醇抗藥性腎症候群兒童進行靜脈注射環磷酰胺治療。
Pediatr Nephrol 2024-02-28
Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases.
評估與不同免疫抑制治療相關的腎小球疾病心血管事件風險。
Kidney Int 2024-11-08
Long Term Evaluations of First Single-dose Rituximab in Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome.
長期評估首次單劑量 Rituximab 在類固醇依賴性最小變化腎病症候群兒童中的效果。
Ren Fail 2024-11-27
Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome.
特發性腎病綜合症中循環因子和生物標記的過去與未來的體外和體內研究方法。
Pediatr Nephrol 2025-01-30